News

20252024202320222021

Irfan Rahman quoted in "Nicotine-free’ vapes and pouches promise a buzz without the downsides. Health concerns remain"

Thursday, September 18, 2025

In the past couple of years, “nicotine-like” products have hit the market in the U.S., Europe, Australia and South Korea. They look like nicotine vapes and pouches, with similar flavors and sleek designs. Some provide a nicotine-like buzz.

But there’s a crucial difference: Outside Europe, these products aren’t subject to government oversight.

Researchers warn that at least one of these products’ nicotine-like chemicals, called nicotine analogs, may be more potent and addictive than nicotine itself — and that these products are sometimes marketed in misleading ways.

Nicotine analogs are synthetic, chemical compounds that closely resemble nicotine. Some activate the same brain receptors as nicotine, with a similar buzz and addictive properties.

These compounds aren’t new; tobacco companies started researching nicotine analogs in the 1970s in anticipation of future regulations that could reduce how much nicotine would be allowed in their products, according to a study of industry documents. But the companies feared this research would trigger more regulation, so the studies were shelved. 

In 2022, the U.S. Congress acted in response to the proliferation of vapes containing synthetic nicotine. That lab-made compound has the same chemical structure and properties as nicotine extracted from tobacco, so lawmakers authorized the U.S. Food and Drug Administration to regulate products containing synthetic nicotine just as it does those containing naturally occurring nicotine. 

After that, the industry showed renewed interest in nicotine analogs. Products containing these compounds soon appeared on the market.

“These products were intentionally designed to bypass regulation,” said Sven Eric Jordt, a professor of pharmacology and cancer biology at Duke University who has studied nicotine analogs.

Though sales data is limited, research studies say the market for nicotine alternatives is growing. Some companies that produce vapes containing nicotine also produce vapes with nicotine-like ingredients.

Irfan Rahman, a professor of environmental pulmonary health and disease at the University of Rochester, analyzed research studies of 6-methyl nicotine and found that it may cause more inflammation in lung capillary cells than nicotine. 6-methyl nicotine can damage those cells, potentially contributing to lung diseases such as chronic obstructive pulmonary disease (COPD) and lung cancer, he said.

Irfan Rahman is honored as a ScholarGPS Highly Ranked Scholar

Wednesday, August 6, 2025

Dr. Rahman has been ranked in the top 0.02% worldwide and in the top 26 at the University of Rochester in his field.

Congratulations!

Forever Chemicals, Lasting Effects: Prenatal PFAS Exposure Shapes Baby Immunity

Wednesday, July 23, 2025

New research reveals that tiny amounts of PFAS—widely known as “forever chemicals”—cross the placenta and breast milk to alter infants’ developing immune systems, potentially leaving lasting imprints on their ability to fight disease.

University of Rochester Medical Center (URMC) researchers tracked 200 local healthy mother–baby pairs, measuring common PFAS compounds in maternal blood during pregnancy and then profiling infants’ key T‑cell populations at birth, six months, and one year. By age 12 months, babies whose mothers had higher prenatal PFAS exposure exhibited significantly fewer T follicular helper (Tfh) cells—vital coaches that help B cells produce strong, long‑lasting antibodies—and disproportionately more Th2, Th1, and regulatory T cells (Tregs), each linked to allergies, autoimmunity, or immune suppression when out of balance.

“This is the first study to identify changes in specific immune cells that are in the process of developing at the time of PFAS exposure,” said Kristin Scheible, MD, an associate professor of Pediatrics and Microbiology & Immunology at URMC and lead author of the study, which appears in the journal Environmental Health Perspectives. “Identification of these particular cells and pathways opens up the potential for early monitoring or mitigation strategies for the effects of PFAS exposure, in order to prevent lifelong diseases.”

Dr. Elder featured in Nature: "Your brain is full of microplastics: are they harming you?"

Tuesday, February 11, 2025

Plastics might affect each organ or cell type differently. The dose matters, too, as well as the route of ingestion, says Alison Elder, an associate professor of environmental medicine. “The inhalation route is a major concern because if inhaled plastics can get into the deep lung and cause an inflammatory reaction, they don’t need to go anywhere to cause health outcomes.”